Hill Emily Luisa — SEC insider filings
SEC reporting owner CIK 1778279. 28 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2021-01-07 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 26 legs across 21 filings — 110,470 shares, $3,487,040 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 10,500 shares @ $69.75 ($732,375) in PTC THERAPEUTICS, INC., filed 2021-01-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. (PTCT) | CHIEF FINANCIAL OFFICER | 16 | — | 19 legs · 46,618 sh · $2,688,432 | 14 |
| Replimune Group, Inc. (REPL) | Chief Financial Officer | 12 | — | 7 legs · 63,852 sh · $798,608 | 9 |
Insider filings — Hill Emily Luisa
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 14,709 @ $21.60 | EDGAR |
| 2026-08-19 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 9,256 @ $14.28 | EDGAR |
| 2026-08-12 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 11,448 @ $12.97 | EDGAR |
| 2026-05-20 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 7,812 @ $5.08 | EDGAR |
| 2026-04-07 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 60,000 @ $0 | EDGAR |
| 2025-08-19 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 9,154 @ $5.37 | EDGAR |
| 2025-05-22 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 2,535 @ $8.05 | EDGAR |
| 2025-04-03 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 45,000 @ $0 · Grant/award (A): 67,500 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 8,938 @ $10.18 | EDGAR |
| 2024-04-03 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 26,665 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-09-20 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 83,330 @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-03-29 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 7,363 @ $45 | EDGAR |
| 2023-02-02 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 575 @ $45.63 | EDGAR |
| 2023-01-26 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 223 @ $47.45 | EDGAR |
| 2023-01-12 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 497 @ $42.93 · Sale (S): 418 @ $44.36 | EDGAR |
| 2023-01-11 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 758 @ $41.66 | EDGAR |
| 2023-01-09 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 19,500 @ $0 · Grant/award (A): 42,500 (derivative) @ $0 | EDGAR |
| 2022-04-01 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 7,910 @ $37.78 | EDGAR |
| 2022-02-03 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 553 @ $40.00 | EDGAR |
| 2022-01-27 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 211 @ $39.31 | EDGAR |
| 2022-01-11 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 800 @ $38.52 · Grant/award (A): 15,600 @ $0 · Grant/award (A): 58,500 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 173 @ $41.16 | EDGAR |
| 2021-02-02 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 541 @ $56.96 | EDGAR |
| 2021-01-27 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 275 @ $62.05 | EDGAR |
| 2021-01-12 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Option exercise (M): 2,430 @ $30.86 · Sale (S): 2,430 @ $69.75 · Option exercise (M): 3,825 @ $11.23 · Sale (S): 3,825 @ $69.75 · Option exercise (M): 10,500 @ $18.01 · Sale (S): 10,500 @ $69.75 · +6 more | EDGAR |
| 2021-01-08 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Grant/award (A): 10,800 @ $0 · Grant/award (A): 63,000 (derivative) @ $0 | EDGAR |
| 2021-01-07 | 4 | PTC THERAPEUTICS, INC. (PTCT) | Sale (S): 112 @ $62.37 · Sale (S): 176 @ $62.37 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1778279 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs